BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9158667)

  • 1. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
    Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
    Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
    Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
    Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding and thrombosis in acute promyelocytic leukemia.
    Choudhry A; DeLoughery TG
    Am J Hematol; 2012 Jun; 87(6):596-603. PubMed ID: 22549696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral venous and sinus thrombosis in a patient with acute promyelocytic leukemia during all-trans retinoic acid induction treatment.
    Song LX; Lu HY; Chang CK; Li X; Zhang Z
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):773-6. PubMed ID: 24717424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia.
    Goldschmidt N; Gural A; Ben Yehuda D
    Leuk Lymphoma; 2003 Aug; 44(8):1433-7. PubMed ID: 12952241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
    Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
    Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation.
    Koçak U; Gürsel T; Oztürk G; Kantarci S
    Pediatr Hematol Oncol; 2000 Mar; 17(2):177-80. PubMed ID: 10734661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary embolism and thrombotic thrombocytopenic purpura in acute promyelocytic leukemia treated with all-trans retinoic acid.
    Fujita H; Takemura S; Hyo R; Tanaka M; Koharazawa H; Fujisawa S; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2003 Sep; 44(9):1627-9. PubMed ID: 14565670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
    Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid].
    Medvedeva NA; Cherepanova VV; Tarasova LN; Kudriavtseva AV; Kostin AI; Kolupaeva OR
    Ter Arkh; 2000; 72(7):27-31. PubMed ID: 10983317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of acute promyelocytic leukemia with all-trans retinoic acid on hemodialysis for acute renal failure].
    Marshall S; Imada H; Kimura A; Ito T; Ogasawara T; Kazama H; Yoshinaga K; Tanaka J; Uchigata Y; Ogawa T
    Rinsho Ketsueki; 2023; 64(3):193-197. PubMed ID: 37019672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.
    Xiao M; Zhou P; Sun K
    Clin Appl Thromb Hemost; 2022; 28():10760296221080166. PubMed ID: 35187963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
    Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute promyelocytic leukemia following ulcerative colitis].
    Suzuki Y; Nakase K; Nagaya S; Tamaki S; Tanigawa M; Ikeda T; Tsuji K; Miyanishi E
    Rinsho Ketsueki; 1995 Jul; 36(7):707-9. PubMed ID: 7563602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.